NO20031719L - Kontroll av forholdet mellom LAP og LIP - Google Patents

Kontroll av forholdet mellom LAP og LIP

Info

Publication number
NO20031719L
NO20031719L NO20031719A NO20031719A NO20031719L NO 20031719 L NO20031719 L NO 20031719L NO 20031719 A NO20031719 A NO 20031719A NO 20031719 A NO20031719 A NO 20031719A NO 20031719 L NO20031719 L NO 20031719L
Authority
NO
Norway
Prior art keywords
lap
lip
relationship
control
Prior art date
Application number
NO20031719A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031719D0 (no
Inventor
Yohei Hirai
Original Assignee
Sumitomo Electric Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Electric Industries filed Critical Sumitomo Electric Industries
Publication of NO20031719D0 publication Critical patent/NO20031719D0/no
Publication of NO20031719L publication Critical patent/NO20031719L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20031719A 2002-04-12 2003-04-14 Kontroll av forholdet mellom LAP og LIP NO20031719L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002110197 2002-04-12

Publications (2)

Publication Number Publication Date
NO20031719D0 NO20031719D0 (no) 2003-04-14
NO20031719L true NO20031719L (no) 2003-10-13

Family

ID=19193890

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031719A NO20031719L (no) 2002-04-12 2003-04-14 Kontroll av forholdet mellom LAP og LIP

Country Status (11)

Country Link
US (1) US20040002149A1 (de)
EP (1) EP1362867A3 (de)
KR (1) KR20030081187A (de)
CN (1) CN1451752A (de)
AU (1) AU2003203527A1 (de)
CA (1) CA2425021A1 (de)
IL (1) IL155341A0 (de)
NO (1) NO20031719L (de)
NZ (1) NZ525221A (de)
RU (1) RU2003110509A (de)
ZA (1) ZA200302924B (de)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769330A (en) * 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US4797368A (en) * 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) * 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
EP0561034B1 (de) * 1991-08-26 1999-06-09 IMMUNO Aktiengesellschaft Direkt molekuläre Klonierung eines modifizierten Genoms eines Chordopocken-Virus
CA2098397C (en) * 1991-10-16 1999-07-06 Yohei Hirai Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto
US5837239A (en) * 1991-10-16 1998-11-17 Biomaterial Research Institute Co., Ltd. Physiologically active substance designated as epimorphin genes encoding the same and antibodies thereto
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
AU690905B2 (en) * 1993-03-04 1998-05-07 Baylor College Of Medicine The human C/EBP gene and vectors for its expression
FR2709309B1 (fr) * 1993-08-25 1995-11-10 Centre Nat Rech Scient Compositions cellulaires, préparation et utilisations thérapeutiques.
FR2712812B1 (fr) * 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
US5871986A (en) * 1994-09-23 1999-02-16 The General Hospital Corporation Use of a baculovirus to express and exogenous gene in a mammalian cell
US20030166586A1 (en) * 2000-02-18 2003-09-04 Linda Sealy C/EBP beta isoforms and methods of use in cell regulation and anti-tumorigenesis
US6271030B1 (en) * 2000-06-14 2001-08-07 Isis Pharmaceuticals, Inc. Antisense inhibition of C/EBP beta expression

Also Published As

Publication number Publication date
ZA200302924B (en) 2003-10-15
AU2003203527A1 (en) 2003-10-30
CN1451752A (zh) 2003-10-29
EP1362867A3 (de) 2004-06-02
NO20031719D0 (no) 2003-04-14
RU2003110509A (ru) 2005-01-20
KR20030081187A (ko) 2003-10-17
US20040002149A1 (en) 2004-01-01
EP1362867A2 (de) 2003-11-19
IL155341A0 (en) 2003-11-23
NZ525221A (en) 2005-06-24
CA2425021A1 (en) 2003-10-12

Similar Documents

Publication Publication Date Title
DE60326611D1 (de) N und dergleichen
DK1572670T3 (da) 5-substitueret-pyrazin eller -pyridin-glucokinaseaktivatorer
IL164295A0 (en) Tri-substituted heteroaryls and methods of making and using the same
DE60328426D1 (de) Gestaltung der Verschlusselemente
EP1551447A4 (de) Anti-addl-antikörper und ihre verwendungen
IL163940A0 (en) Aryl substituted pyrimidines and the use thereof
EP1501615A4 (de) Zusammenklappbare schaukel und verwendungsverfahren dafür
ZA200407986B (en) Substituted phenylacetamides and their use as glucokinase activators.
ATE550017T1 (de) Lasofoxifen-tablette und ihre ummantelung
PL375355A1 (en) Novel lipases and uses thereof
AU2003239610A8 (en) Tiled biochips and the methods of making the same
EP1581496A4 (de) 2-substituierte 3-propenamidderivate und verfahren zu deren herstellung
IL166063A0 (en) Antibodies and uses thereof
ZA200407845B (en) Laminar materials comprising incorporated property-altering microspheres and the method of producingsame.
EP1484622A4 (de) Prisma und verfahren zu seiner herstellung
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
AU2003282338A8 (en) Determination of protein function
EP1510711A4 (de) Homokinetisches gelenk
DE60331556D1 (de) Beschichtete kapillar-elektrophoreseröhren und system
NO20031719D0 (no) Kontroll av forholdet mellom LAP og LIP
DE50301665D1 (de) Torblatthandgriff sowie Verwendung desselben
FR2843451B1 (fr) Fronde du type lance-pierres
EP1612438A4 (de) Homokinetische kupplung und herstellungsverfahren dafür
AU2002361488A1 (en) Field and background of the invention
EP1691091A4 (de) Homokinetische kupplung und herstellungsverfahren dafür

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application